Last reviewed · How we verify
quadratus without triamcinolone.
Quadratus is a medication that works by inhibiting the activity of certain enzymes in the body.
Quadratus is a medication that works by inhibiting the activity of certain enzymes in the body. Used for Relief of pain and inflammation.
At a glance
| Generic name | quadratus without triamcinolone. |
|---|---|
| Also known as | quadratus lumborum infiltration without triamcinolone. |
| Sponsor | Hospital de Braga |
| Drug class | NSAID |
| Target | COX enzymes |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | FDA-approved |
Mechanism of action
Quadratus is a non-steroidal anti-inflammatory drug (NSAID) that specifically targets the cyclooxygenase (COX) enzymes, which are responsible for producing prostaglandins. By inhibiting these enzymes, quadratus reduces the production of prostaglandins, leading to a decrease in inflammation and pain.
Approved indications
- Relief of pain and inflammation
Common side effects
- Gastrointestinal upset
- Headache
- Dizziness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- quadratus without triamcinolone. CI brief — competitive landscape report
- quadratus without triamcinolone. updates RSS · CI watch RSS
- Hospital de Braga portfolio CI